CancerNext analyzes 36 genes. These genes (excluding EPCAM and GREM1) are evaluated by next generation sequencing (NGS) or Sanger sequencing of all coding domains, and well into the flanking 5’ and 3’ ends of all the introns and untranslated regions.
Breast Cancer, Colorectal Cancer, Melanoma, Ovarian Cancer, Uterine Cancer
APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), AXIN2 (Axin 2), BARD1 (BRCA1 Associated RING Domain 1), BMPR1A (Bone Morphogenetic Protein Receptor Type 1A), BRCA1 (Breast cancer 1, early onset)
See More ...
Next-Generation Sequencing (NGS)